Hybridex Biosciences

Envisioning safe and efficacious next-generation gene editing therapeutics @Yale @YaleMed

[Hybridex Biosciences @HybridexBio]

You can connect with us – and the other #startups in the cohort – during the #MassBioDrive ecosystem networking mixer on 10/26: https://t.co/EJ6MVvdxgT (3/3)

[Hybridex Biosciences @HybridexBio]

We’re proud to announce that Hybridex has been chosen to participate in @MassBio’s #MassBioDrive fall 2022 cohort! https://t.co/BpnXpeUVkc (1/3)

[Hybridex Biosciences @HybridexBio]

We’re excited to accelerate the growth of Hybridex over the next eight weeks with hands-on expert guidance, mentorship from #biopharma leaders, and by expanding our industry network. (2/3)

[MassBio @MassBio]

We are pleased to announce the six emerging startups chosen to participate in the #MassBioDrive Fall 2022 Cohort: AdductNE, @HDAXtx, @HybridexBio, Jenthera Therapeutics Inc., Orion, and pacDNA https://t.co/UphT6uhMFE